ciprofloxacin has been researched along with Leg Ulcer in 12 studies
Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.
Leg Ulcer: Ulceration of the skin and underlying structures of the lower extremity. About 90% of the cases are due to venous insufficiency (VARICOSE ULCER), 5% to arterial disease, and the remaining 5% to other causes.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Forty-eight patients with peripheral vascular disease (46 with diabetes mellitus) who presented to the hospital for treatment of lower extremity infections were randomized in a blinded fashion to receive oral ciprofloxacin at a dosage of either 750 mg or 1,000 mg twice daily." | 9.06 | Therapy of lower extremity infections with ciprofloxacin in patients with diabetes mellitus, peripheral vascular disease, or both. ( Canter, K; Clabots, C; Fasching, CE; Gerding, DN; Lissack, LM; Peterson, LR, 1989) |
| "Ciprofloxacin was clinically more effective than the standard therapy in reducing the size of the ulcer (p less than 0." | 6.66 | A comparative study of ciprofloxacin and conventional therapy in the treatment of patients with chronic lower leg ulcers infected with Pseudomonas aeruginosa or other gram-negative rods. ( Kariniemi, AL; Karppinen, L; Valtonen, V, 1989) |
| "Forty-eight patients with peripheral vascular disease (46 with diabetes mellitus) who presented to the hospital for treatment of lower extremity infections were randomized in a blinded fashion to receive oral ciprofloxacin at a dosage of either 750 mg or 1,000 mg twice daily." | 5.06 | Therapy of lower extremity infections with ciprofloxacin in patients with diabetes mellitus, peripheral vascular disease, or both. ( Canter, K; Clabots, C; Fasching, CE; Gerding, DN; Lissack, LM; Peterson, LR, 1989) |
| "The aims of this study were to evaluate factors influencing the distribution of ciprofloxacin in tissue of patients suffering from varying degrees of peripheral arterial disease (PAD)." | 3.83 | Factors Affecting Penetration of Ciprofloxacin in Lower Extremity Ischemic Tissues. ( Azzopardi, LM; Camilleri, L; Cassar, K; LaFerla, G; Serracino-Inglott, A; Vella, J; Vella, M, 2016) |
| "Ciprofloxacin was clinically more effective than the standard therapy in reducing the size of the ulcer (p less than 0." | 2.66 | A comparative study of ciprofloxacin and conventional therapy in the treatment of patients with chronic lower leg ulcers infected with Pseudomonas aeruginosa or other gram-negative rods. ( Kariniemi, AL; Karppinen, L; Valtonen, V, 1989) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (16.67) | 18.7374 |
| 1990's | 3 (25.00) | 18.2507 |
| 2000's | 1 (8.33) | 29.6817 |
| 2010's | 3 (25.00) | 24.3611 |
| 2020's | 3 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Salm, J | 1 |
| Böhme, T | 1 |
| Noory, E | 1 |
| Beschorner, U | 1 |
| Kramer, TS | 1 |
| Westermann, D | 1 |
| Zeller, T | 1 |
| Dilhari, A | 1 |
| Pathirage, S | 1 |
| Gunasekara, C | 1 |
| Fernando, N | 1 |
| Weerasekara, D | 1 |
| McBain, A | 1 |
| Weerasekera, M | 1 |
| Pires, BMFB | 1 |
| de Oliveira, BGRB | 1 |
| de Oliveira, FP | 1 |
| de Almeida Silva, KCF | 1 |
| Del Peloso, PF | 1 |
| Ferreira-Carvalho, BT | 1 |
| de Paula, GR | 1 |
| Teixeira, LA | 1 |
| Vella, J | 1 |
| Vella, M | 1 |
| Cassar, K | 1 |
| Camilleri, L | 1 |
| Serracino-Inglott, A | 1 |
| Azzopardi, LM | 1 |
| LaFerla, G | 1 |
| Grocholski, AS | 1 |
| Delage, M | 1 |
| Samimi, M | 1 |
| Maruani, A | 1 |
| Rozin, AP | 1 |
| Egozi, D | 1 |
| Ramon, Y | 1 |
| Toledano, K | 1 |
| Braun-Moscovici, Y | 1 |
| Markovits, D | 1 |
| Schapira, D | 1 |
| Bergman, R | 1 |
| Melamed, Y | 1 |
| Ullman, Y | 1 |
| Balbir-Gurman, A | 1 |
| Bousquet, A | 1 |
| Demoures, T | 1 |
| Malfuson, JV | 1 |
| Martinaud, C | 1 |
| Soler, C | 1 |
| Livasy, CA | 1 |
| Kaplan, AM | 1 |
| Colsky, AS | 1 |
| Kirsner, RS | 1 |
| Kerdel, FA | 1 |
| Semret, M | 1 |
| Koromihis, G | 1 |
| MacLean, JD | 1 |
| Libman, M | 1 |
| Ward, BJ | 1 |
| Valtonen, V | 1 |
| Karppinen, L | 1 |
| Kariniemi, AL | 1 |
| Peterson, LR | 1 |
| Lissack, LM | 1 |
| Canter, K | 1 |
| Fasching, CE | 1 |
| Clabots, C | 1 |
| Gerding, DN | 1 |
1 review available for ciprofloxacin and Leg Ulcer
| Article | Year |
|---|---|
Ciprofloxacin-induced toxic epidermal necrolysis: a case report.
Topics: Adult; Aged; Anti-Infective Agents; Ciprofloxacin; Fatal Outcome; Female; Humans; Leg Ulcer; Male; M | 1997 |
2 trials available for ciprofloxacin and Leg Ulcer
| Article | Year |
|---|---|
A comparative study of ciprofloxacin and conventional therapy in the treatment of patients with chronic lower leg ulcers infected with Pseudomonas aeruginosa or other gram-negative rods.
Topics: Administration, Oral; Aged; Bacterial Infections; Chlorhexidine; Ciprofloxacin; Disinfectants; Drug | 1989 |
Therapy of lower extremity infections with ciprofloxacin in patients with diabetes mellitus, peripheral vascular disease, or both.
Topics: Adult; Bacteria; Bacterial Infections; Ciprofloxacin; Clinical Trials as Topic; Diabetes Complicatio | 1989 |
9 other studies available for ciprofloxacin and Leg Ulcer
| Article | Year |
|---|---|
Arterial leg ulcers-Bacterial patterns, antimicrobial resistance and clinical characteristics, a retrospective single-centre cohort, 2012-2021.
Topics: Anti-Bacterial Agents; Bacteria; Ciprofloxacin; Clindamycin; Drug Resistance, Bacterial; Escherichia | 2023 |
Topics: Aged; Anti-Bacterial Agents; Anti-Infective Agents, Local; Cefuroxime; Ciprofloxacin; Cloxacillin; D | 2020 |
Ciprofloxacin-Resistant Kerstersia gyiorum Isolated From a Chronic Wound in Brazil: A Case Report.
Topics: Aged, 80 and over; Alcaligenaceae; Brazil; Ciprofloxacin; Disease Resistance; Female; Humans; Leg Ul | 2020 |
Factors Affecting Penetration of Ciprofloxacin in Lower Extremity Ischemic Tissues.
Topics: Aged; Amputation, Surgical; Anti-Bacterial Agents; Chromatography, Liquid; Ciprofloxacin; Debridemen | 2016 |
[Acute dermohypodermitis of the right leg (S. putrefaciens) after sea bathing].
Topics: Acute Disease; Aged; Anti-Infective Agents; Ciprofloxacin; Humans; Leg Ulcer; Male; Oceans and Seas; | 2009 |
Large leg ulcers due to autoimmune diseases.
Topics: Animals; Antibodies, Monoclonal; Autoimmune Diseases; Azathioprine; Ciprofloxacin; Cyclophosphamide; | 2011 |
Campylobacter jejuni cutaneous infection in a patient with graft versus host disease.
Topics: Campylobacter Infections; Campylobacter jejuni; Ciprofloxacin; Erysipelas; Graft vs Host Disease; He | 2012 |
Analysis of antibiotic susceptibilities of skin wound flora in hospitalized dermatology patients. The crisis of antibiotic resistance has come to the surface.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Dermatitis; Drug Resistance, Microbial; | 1998 |
Mycobacterium ulcerans infection (Buruli ulcer): first reported case in a traveler.
Topics: Adult; Africa; Anti-Bacterial Agents; Antibiotics, Antitubercular; Antitubercular Agents; Ciprofloxa | 1999 |